| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/08/2007 | CN101011356A Aerosol and its preparation |
| 08/08/2007 | CN101011355A Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof |
| 08/08/2007 | CN101011354A Asarone submicron emulsion and its preparation method |
| 08/08/2007 | CN101011353A Anti-cancer composition loading both platinum compound and alkylating agent |
| 08/08/2007 | CN101011352A Anti-cancer composition loading both mtrosourea medicament and guanopterin analog |
| 08/08/2007 | CN101011351A Anti-cancer composition loading both platinum compound and synergist |
| 08/08/2007 | CN101011350A Anti solid tumor composition |
| 08/08/2007 | CN101011349A Slow release injection containing mtrosourea medicament and topoisomerase inhibitor |
| 08/08/2007 | CN101011348A Anti-cancer composition loading both mtrosourea medicament and alkaloids medicament |
| 08/08/2007 | CN101011347A Slow release injection containing platinum compound and topoisomerase inhibitor |
| 08/08/2007 | CN101011346A Anti-cancer composition loading both mtrosourea medicament and synergist |
| 08/08/2007 | CN101011345A Slow release injection containing platinum compound and alkylating agent |
| 08/08/2007 | CN101011344A Anti-cancer composition loading both mtrosourea medicament and alkylating agent |
| 08/08/2007 | CN101011343A Slow release injection containing anti-metabolism medicament and alkylating agent |
| 08/08/2007 | CN101011342A Slow release injection containing anti-metabolism medicament and platinum compound |
| 08/08/2007 | CN101011341A Slow release injection containing anti-metabolism medicament and topoisomerase inhibitor |
| 08/08/2007 | CN101011340A Anti-cancer composition loading both anti-metabolism medicament and alkylating agent |
| 08/08/2007 | CN101011058A Disinfectant and/or bactericidal aqueous compositions |
| 08/07/2007 | US7253262 Dried blood factor composition comprising trehalose |
| 08/07/2007 | US7253254 Polypeptide variants with increased heparin-binding capacity |
| 08/07/2007 | US7253209 Dissolving in iodinated poppyseed oil fatty ester |
| 08/07/2007 | US7253207 Quinones as disease therapies |
| 08/07/2007 | US7253147 Gentically engineered serum albumin comprising three-amino acid truncation at its n-terminal and decreased receptivity for trace metals for use in cosmetic and pharmaceutical preparations |
| 08/07/2007 | US7253142 Protein solution preparation and method of stabilizing the same |
| 08/07/2007 | US7252960 Test kit for intracellular introduction of protein and/or peptide and method of intracellular introduction |
| 08/07/2007 | US7252842 Encapsulation of hydrophilic active agents in biodegradable polymers; employs a minimal volume of surfactant solution resulting in a reduced production time |
| 08/07/2007 | US7252799 Methods for sterilizing preparations containing albumin |
| 08/07/2007 | CA2434655C Cubic liquid crystalline phase precursor |
| 08/07/2007 | CA2407952C Growth factor modified protein matrices for tissue engineering |
| 08/07/2007 | CA2361392C Premixed formulation of piperacillin sodium and tazobactam sodium injection |
| 08/07/2007 | CA2351536C Therapeutic anti-fungal nail preparation |
| 08/07/2007 | CA2325842C Methods for making and delivering rho-antagonist tissue adhesive formulations to the injured mammalian central and peripheral nervous systems and uses thereof |
| 08/07/2007 | CA2324887C Ophthalmic composition comprising a .beta.-blocker |
| 08/07/2007 | CA2316981C Pharmaceutical composition containing bupropion hydrochloride and a stabilizer |
| 08/07/2007 | CA2301799C Novel conjugates of opioids and endogenous carriers |
| 08/07/2007 | CA2292953C High-activity phytase granulate |
| 08/07/2007 | CA2289196C Sustained-release delayed gels |
| 08/07/2007 | CA2289088C Microparticles useful as ultrasonic contrast agents and for delivery of drugs into the bloodstream |
| 08/07/2007 | CA2281946C Pharmaceutical formulations containing poorly soluble drug substances |
| 08/07/2007 | CA2252374C A process for viral inactivation of lyophilized blood proteins |
| 08/07/2007 | CA2246568C Phosphatidyl oligoglycerols |
| 08/07/2007 | CA2246378C Isolation and use of sh3 binding peptides |
| 08/07/2007 | CA2244679C Tranilast-containing preparation for external application and method of producing the same |
| 08/07/2007 | CA2234282C Drug-resin complexes stabilized by chelating agents |
| 08/07/2007 | CA2184842C New stabilized galenic formulations comprising an acid labile benzimidazole compound and its preparation |
| 08/07/2007 | CA2132265C Anti-sense oligonucleotides against hsv-1, and their preparation |
| 08/07/2007 | CA2124801C Gonadotropin containing pharmaceutical compositions with sucrose stabilizer |
| 08/02/2007 | WO2007086931A1 Dosage regimen and medicament for preventing of reducing risk of onset or progression of dementia by administration of specific vitamins and nsaid |
| 08/02/2007 | WO2007086694A1 Zaltoprofen-containing sustained release tablet and process for the preparation thereof |
| 08/02/2007 | WO2007086692A1 Multiple unit type sustained release oral formulation and process for the preparation thereof |
| 08/02/2007 | WO2007086613A1 Enzymatically crosslinked protein nanoparticles |
| 08/02/2007 | WO2007086587A1 Agent for targeting drug to cerebral neuron |
| 08/02/2007 | WO2007086586A1 Low-moisture-content hard capsule and production method therefor |
| 08/02/2007 | WO2007086582A1 OIL-IN-WATER TYPE EMULSION LOTION CONTAINING 22-OXA-1α,25-DIHYDROXYVITAMIN D3 AND METHOD OF TREATING SKIN DISEASE BY USING THE SAME |
| 08/02/2007 | WO2007086541A2 Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound |
| 08/02/2007 | WO2007086493A1 Medicine for transnasal administration |
| 08/02/2007 | WO2007086457A1 Quickly disintegrating tablet produced by direct dry-tabletting |
| 08/02/2007 | WO2007086306A1 Biodegradable inverted-opal structure, method for production of the same, use of the same, and medical implant comprising the same |
| 08/02/2007 | WO2007085887A1 Pyy agonists and uses thereof |
| 08/02/2007 | WO2007085702A1 New biodegradable polymers |
| 08/02/2007 | WO2007085629A2 Use of hyaluronic acid as a carrier molecule for?different classes of therapeutic active agents |
| 08/02/2007 | WO2007085615A1 Process for loading polymer particles with drug |
| 08/02/2007 | WO2007085498A1 Pharmaceutical forms in film form for use in the mouth (wafers) |
| 08/02/2007 | WO2007085084A1 Recombinant human epo-fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo |
| 08/02/2007 | WO2007068311A9 Oral delivery of protein drug using microemulsion |
| 08/02/2007 | WO2007067582A3 Process for manufacturing chewable dosage forms for drug delivery and products thereof |
| 08/02/2007 | WO2007057201A3 Pharmaceutical composition free from dexpanthenol, calcium ions, and phosphate, and use of calcium chelating agent and ophthalmologically compatible viscosity regulator |
| 08/02/2007 | WO2007057178A3 Angiogenesis-promoting substrate |
| 08/02/2007 | WO2007048220A3 Trazodone composition for once a day adminisitiation |
| 08/02/2007 | WO2007041482A3 Topical anesthetic for dental procedures |
| 08/02/2007 | WO2007040653A3 Anti-cd30 antibodies that bind to intact cd30 but not soluble cd30 |
| 08/02/2007 | WO2007036745A3 Interleukin-13 antibody composition |
| 08/02/2007 | WO2007022070A3 Modified fc molecules |
| 08/02/2007 | WO2007016093A3 Peroxide removal from drug delivery vehicle |
| 08/02/2007 | WO2007009989A3 COMPOSITION CONTAINING A SIO2-NANOPARTICLE LIPOSOMAL DISPERSION AND AN ß-1,3-LINKED GLUCAN-ETHER DERIVATIVE |
| 08/02/2007 | WO2007002233A3 Low-toxicity, long-circulating chimeras of human interferon- alpha analogs and interferon tau |
| 08/02/2007 | WO2006131923A3 Novel salts of conjugated psychotropic drugs and processes of preparing same |
| 08/02/2007 | WO2006087354A3 Insulinotropic agents conjugated with structurally well defined branched polymers |
| 08/02/2007 | WO2006068867A9 Combination therapy for b cell disorders |
| 08/02/2007 | US20070179274 having terminal carboxylic acid or carboxylic acid derivative group that is sterically hindered by an alkyl or aryl group on the alpha-carbon, which enables greater control of the rate of hydrolytic degradation of polymer derivatives; solvent precipitation; biodrug conjugates |
| 08/02/2007 | US20070179176 Monohydrated sodium salt of s-tenatoprazole and the use thereof in therapy |
| 08/02/2007 | US20070179093 Growth factor modified protein matrices for tissue engineering |
| 08/02/2007 | US20070179087 Method for treating inflammatory diseases using heat shock proteins |
| 08/02/2007 | US20070178143 Methods for Altering Food Intake by Animals |
| 08/02/2007 | US20070178140 Compositions and methods for reducing food intake and controlling weight |
| 08/02/2007 | US20070178126 Polyamino acids functionalized by at least one (oligo)amino acid group and therapeutic uses |
| 08/02/2007 | US20070178101 Ovr110 antibody compositions and methods of use |
| 08/02/2007 | US20070178094 Autoimmune diseases; antitumor agents; antiallergens; enhancing the immune response of an individual to a specific molecule, by enhancing the MHC class II presentation of an antigenic epitope of the molecule to T lymphocytes of the individual |
| 08/02/2007 | US20070178078 Method for Modifying Gut Flora in Animals |
| 08/02/2007 | US20070178052 Delivery of opioids through an inhalation route |
| 08/02/2007 | US20070175472 Dpi formulation containing sulfoalkyl ether cyclodextrin |
| 08/02/2007 | DE102006003512A1 Plättchenförmige Arzneimittel zur transbukkalen Applikation von Arzneistoffen Plate-like drugs for transbukkalen application of drugs |
| 08/02/2007 | DE102004046172B4 Offenporiger Polyurethanschaum ohne Hautbildung, Formulierung zu seiner Herstellung und Verwendung desselben Of the same open-cell polyurethane foam without skin formation, formulation for its preparation and use |
| 08/02/2007 | DE10138935B4 Synthetische Verbindungen vom Nicht-Mucintyp oder ihre mit einem Träger konjugierten Verbindungen, unter deren Verwendung hergestellte monoclonale Antikörper, diese umfassende Antitumormittel Immunstimulantien und Mittel gegen das humane Immundefizienzvirus Synthetic compounds from non-mucin or its conjugated with a carrier compounds monoclonal antibody prepared using them, this comprehensive antitumor agents and immunostimulants agents against human immunodeficiency virus |
| 08/02/2007 | CA2650072A1 Recombinant human epo-fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo |
| 08/02/2007 | CA2640376A1 Antimicrobial ceramic material comprising metal species |
| 08/02/2007 | CA2640170A1 New biodegradable polymers |
| 08/02/2007 | CA2640159A1 Use of hyaluronic acid as a carrier molecule for different classes of therapeutic active agents |
| 08/02/2007 | CA2637941A1 Anti-infective solution comprising a compound of pyrido(3,2,1-ij)-benzoxadiazine type |
| 08/02/2007 | CA2637300A1 Pharmaceutical forms in film form for use in the mouth (wafers) |